IT1263957B - Impiego terapeutico del pirrolidon carbossilato di piridossina - Google Patents

Impiego terapeutico del pirrolidon carbossilato di piridossina

Info

Publication number
IT1263957B
IT1263957B ITMI930341A ITMI930341A IT1263957B IT 1263957 B IT1263957 B IT 1263957B IT MI930341 A ITMI930341 A IT MI930341A IT MI930341 A ITMI930341 A IT MI930341A IT 1263957 B IT1263957 B IT 1263957B
Authority
IT
Italy
Prior art keywords
carboxylate
pyrolidon
pyridoxy
therapeutic use
fatty acids
Prior art date
Application number
ITMI930341A
Other languages
English (en)
Italian (it)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ITMI930341A priority Critical patent/IT1263957B/it
Publication of ITMI930341A0 publication Critical patent/ITMI930341A0/it
Priority to TW082104060A priority patent/TW230749B/zh
Priority to PCT/EP1994/000518 priority patent/WO1994018965A1/en
Publication of ITMI930341A1 publication Critical patent/ITMI930341A1/it
Application granted granted Critical
Publication of IT1263957B publication Critical patent/IT1263957B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
ITMI930341A 1993-02-23 1993-02-23 Impiego terapeutico del pirrolidon carbossilato di piridossina IT1263957B (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITMI930341A IT1263957B (it) 1993-02-23 1993-02-23 Impiego terapeutico del pirrolidon carbossilato di piridossina
TW082104060A TW230749B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-02-23 1993-05-22
PCT/EP1994/000518 WO1994018965A1 (en) 1993-02-23 1994-02-19 Therapeutic use of pyridoxine pyrrolidone carboxylate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI930341A IT1263957B (it) 1993-02-23 1993-02-23 Impiego terapeutico del pirrolidon carbossilato di piridossina

Publications (3)

Publication Number Publication Date
ITMI930341A0 ITMI930341A0 (it) 1993-02-23
ITMI930341A1 ITMI930341A1 (it) 1994-08-23
IT1263957B true IT1263957B (it) 1996-09-05

Family

ID=11365120

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI930341A IT1263957B (it) 1993-02-23 1993-02-23 Impiego terapeutico del pirrolidon carbossilato di piridossina

Country Status (3)

Country Link
IT (1) IT1263957B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW230749B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1994018965A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
DE60023125T2 (de) 1999-03-08 2006-06-22 University Of Manitoba, Winnipeg Pyridoxal-analoge zur behandlung von störungen ausgelöst durch einen vitamin b6 mangel
WO2001003682A2 (en) 1999-07-13 2001-01-18 Medicure Inc. Use of pyridoxin derivatives for the treatment of diabetes and related complications
AU783855B2 (en) 1999-08-24 2005-12-15 Medicure International Inc. Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds
AU3718501A (en) 2000-02-29 2001-09-12 Medicure Int Inc Cardioprotective phosphonates and malonates
US7442689B2 (en) 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
AU784840B2 (en) 2000-03-28 2006-07-06 Medicure International Inc. Treatment of cerebrovascular disease
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US7459468B2 (en) 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
IL187159A0 (en) 2007-07-03 2009-02-11 Gur Megiddo Use of metadoxine in relief of alcohol intoxication
AU2007362353A1 (en) * 2007-12-12 2009-06-18 Northern Innovations And Formulations Corp. Preparations containing pyridoxine and alpha-hydroxyisocaproic acid (HICA)
US20110294859A1 (en) 2008-07-29 2011-12-01 Alcobra Ltd. Substituted pyridoxine-lactam carboxylate salts
CA2766107A1 (en) 2009-06-25 2010-12-29 Alcobra Ltd. A method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2485372B1 (fr) * 1980-06-30 1985-08-09 Baldacci Lab Spa Composition pharmaceutique pour le traitement des etats d'intoxication alcoolique aigue a base de 5-oxo-2-pyrrolidone carboxylate de pyridoxine et procede de preparation de ce dernier

Also Published As

Publication number Publication date
TW230749B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1994-09-21
WO1994018965A1 (en) 1994-09-01
ITMI930341A1 (it) 1994-08-23
ITMI930341A0 (it) 1993-02-23

Similar Documents

Publication Publication Date Title
IT1263957B (it) Impiego terapeutico del pirrolidon carbossilato di piridossina
PT1239849E (pt) Formulacoes farmaceuticas que compreendem resveratrol e a sua utilizacao
DE3850109D1 (de) 13-trans-retinsäureester.
ES2145118T3 (es) Derivados de acidos grasos y composiciones farmaceuticas que los contienen.
AR007989A1 (es) Un metodo para reducir el nivel de lipidos en el suero, colesterol y/o trigliceridos y tratar enfermedades relacionadas en una especie de mamiferosmediante una combinacion de un inhibidor de las proteinas de transferencia de trigliceridos microsomales (mtp) y otro agente de reduccion del colesterol, y
DE60116625D1 (de) Therapeutische kombinationen von fettsäuren
ES2181993T3 (es) Composiciones para el cuidado de la piel que contienen retinol o ester de retinilo.
PT1227820E (pt) Acidos oligossacarido-aldonicos e sua utilizacao topica
ATE99928T1 (de) Ester des retinols und/oder der retinsaeure enthaltende aerosol-inhalate.
SE8702980D0 (sv) Therapeutic use of serotonin antagonists
ES2139132T3 (es) Composiciones farmaceuticas activas en la terapia de desordenes del sueño.
ATE231885T1 (de) Verwendung von komplement-inhibitoren zur herstellung eines arzneimittels zur prophylaxe und therapie von entzündlichen darm- und hauterkrankungen sowie purpura
DE3778699D1 (de) Verwendung von vitamin e zur herstellung von arzneimitteln zur normalisierung der blutgerinnung bei therapie mit hochungesaettigten fettsaeuren vom omega-3-typ.
ES2141925T3 (es) Esteres altamente reactivos de carboxi polisacaridos y nuevos carboxi polisacaridos derivados de los mismos.
ES2059880T3 (es) Utilizacion del acido estearidonico para el tratamiento de las enfermedades inflamatorias.
WO1995013071A3 (en) Treatment of immunoregulatory disorders
ES2188663T3 (es) Uso de productos que contienen magnesio para el tratamiento o profilaxis de enfermedades neoplasicas o autoinmunes.
ES2107707T3 (es) Empleo de esteres de l-carnitina y acil l-carnitina con hidroxiacidos para produccion de composiciones farmaceuticas para el tratamiento de dermatosis.
ES2135429T3 (es) Derivados de ciclohexano sustituidos para el tratamiento de enfermedades.
DE68926115D1 (de) Verfahren zur behandlung von akne
IT1261696B (it) Uso di esteri sull'ossidrile della l-carnitina con acidi aromatici perprodurre composizioni farmaceutiche per il trattamento di affezioni cutanee.
AR016382A1 (es) Uso de un derivado del acido bencil-indazol metoxialcanoico.
ATE116849T1 (de) Pharmazeutische verwendung von fettsäuren.
IT8023656A0 (it) Procedimento per la produzione dell'enzima colesterolo-esterasi eper idrolisi degli esteri con acidi grassi del colesterolo mediante l'impiego dell'enzima stesso.
ES2072666T3 (es) Esteres de acidos n-alquil 1,4-dihidropiridindicarboxilicos.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970227